Pulmonary rehab for kids with primary immunodeficiency
Part of Genetic & congenital, Immune system & allergy clinical trials.
This study tests whether a pulmonary rehabilitation program helps children aged 6–18 with primary immunodeficiency improve their breathing and physical fitness. If your child has this condition and is not currently having a lung infection or other serious health issues, they may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 18 years old.
- Your child must have a diagnosis of primary immunodeficiency.
- Your child must not have a current lung infection or worsening breathing problems.
- Your child must not have other serious diseases that affect their physical abilities, like neurological or muscle problems.
- Your child must not have participated in a structured exercise program in the last 3 months.
- Your child must be able to understand and follow exercise instructions (no significant cognitive impairment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise program can help children with asthma breathe better and feel stronger. It is for children whose asthma is stable—meaning no recent attacks or medicine changes—and who are healthy enough to exercise safely.
This trial tests an “inspiratory pulmonary rehabilitation” program—guided breathing and exercise training—for children who have obesity and mild asthma. It may help improve breathing control and exercise ability by teaching safe, structured breathing and activity habits.
This study tests a rehab program for children aged 6-17 who have lung damage from a past tuberculosis (TB) infection. The program uses mild-to-moderate physical activity to help improve their breathing and daily life.
This study tests a physical exercise program designed for adults with diffuse interstitial lung disease. It aims to help improve your breathing and daily function through supervised exercise in a pulmonary rehabilitation setting.
This trial tests whether a structured exercise program, done with remote support, is safe and helpful for children with pulmonary hypertension. It aims to improve how well kids function day-to-day while they stay on their usual PH medications.
This trial tests whether pulmonary rehabilitation (supervised breathing and activity training) improves outcomes for adults who need high-flow oxygen. You may be eligible if your breathing and heart/vital signs are stable and your oxygen level is above a certain threshold.
Hear when a new Primary Immunodeficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.